ulcerative colitis. Noninfective enteritis and colitise
Conditions
Interventions
Intervention 1: Intervention 1: prescription of oral drug products of pomegranate peel as the syrup (containing 6 g of dried pomegranate peel) in two equally divided doses along the 4 weeks, which sho
Treatment - Drugs
Placebo
Intervention 1: prescription of oral drug products of pomegranate peel as the syrup (containing 6 g of dried pomegranate peel) in two equally divided doses along the 4 weeks, which should be taken one
Intervention 2: syrup prescribed mix of sugar and water composition in the packaging of food products like pomegranate peel? in total daily 8 cc along 4 weeks? which in two equally divided doses shou
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients 18 and up to 70 years old; ulcerative colitis identified by clinical criteria, laboratory and endoscopic disease is confirmed; informed consent. Exclusion criteria: addiction; lack of consent to participate or continue to participate in the study; pregnant women; a history of hypersensitivity to the ingredients of pomegranate; taking prednisone above 15 mg daily and / or cyclosporine and / or infleximab.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical features of patients with ulcerative colitis. Timepoint: 4 weeks after intervention. Method of measurement: Lichtiger Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: 4 weeks after the start of the intervention. Method of measurement: Patient monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Ali Kamali
School of Traditional Medicine, Shahid Beheshti University of Medical Sciences
Outcome results
None listed